🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

34+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 34 recruiting trials for “Huntington disease

Phase 3RecruitingNCT07326709

A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

🏥 Novartis Pharmaceuticals📍 2 sites📅 Started Mar 2026View details ↗
EARLY_Phase 1RecruitingNCT06634628

iMagemHTT-009- FIH Evaluation of Novel Mutant Huntingtin PET Radioligand [11C]CHDI-00491009

🏥 CHDI Foundation, Inc.📍 1 site📅 Started Feb 2026View details ↗
Phase 2, PHASE3RecruitingNCT07378644

Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease

🏥 Skyhawk Therapeutics, Inc.📍 2 sites📅 Started Jan 2026View details ↗
RecruitingNCT07253038

Evaluation of Three Tests to Assess Social Cognition in Huntington Disease

👨‍⚕️ Asa Petersen, MD PhD, Department of Psychiatry, Skåne University Hospital📍 1 site📅 Started Dec 2025View details ↗
NARecruitingNCT07213648

Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)

🏥 University of Virginia📍 1 site📅 Started Nov 2025View details ↗
NARecruitingNCT06843252

Home-based TDCS (Transcranial Direct Current Stimulation) for Cognitive and Behavioral Symptoms in Huntington's Disease

👨‍⚕️ Thiago Macedo e Cordeiro, MD, MSc, The University of Texas Health Science Center at San Antonio📍 1 site📅 Started Sep 2025View details ↗
RecruitingNCT06774443

Hinting Task for Huntington's Disease

👨‍⚕️ Maraike Coenen, University Medical Center Groningen📍 1 site📅 Started Sep 2025View details ↗
RecruitingNCT06546488

Cognitive Assessment Tools for Huntington's Disease.

🏥 Ohio State University📍 1 site📅 Started Jun 2025View details ↗
NARecruitingNCT07010705

Digital Measures for Clinical Trial Endpoints in Huntington's Disease

👨‍⚕️ Sugitha Maheswaran, BS📍 1 site📅 Started Jun 2025View details ↗
RecruitingNCT06448546

Gut Microbiomes in HD

👨‍⚕️ Amber Southwell, PhD, University of Central Florida📍 1 site📅 Started Jun 2025View details ↗
Phase 2, PHASE3RecruitingNCT06873334

Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With Huntington's Disease

👨‍⚕️ Masoud Mokhtarani, MD, Skyhawk Therapeutics, Inc.📍 11 sites📅 Started May 2025View details ↗
Phase 2RecruitingNCT06853743

The NAD-HD Study: A Study to Investigate Efficacy and Safety of Nicotinamide Riboside Compared With Placebo in Huntington's Disease

👨‍⚕️ Lasse Pihlstrøm, PhD, Oslo University Hospital📍 1 site📅 Started Mar 2025View details ↗
Phase 1, PHASE2RecruitingNCT06826612

A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease

👨‍⚕️ Clinical Trials, Hoffmann-LaRoche📍 5 sites📅 Started Feb 2025View details ↗
NARecruitingNCT06626308

Early Biomarkers in Premanifest Huntington's Disease Gene Carriers: a Pilot Study

🏥 University Hospital, Grenoble📍 1 site📅 Started Feb 2025View details ↗
NARecruitingNCT06626412

Longitudinal SV2A and MRI in Premanifest HD

🏥 Universitaire Ziekenhuizen KU Leuven📍 1 site📅 Started Dec 2024View details ↗
NARecruitingNCT05360082

Comparison Between [11C]UCB-J and [18F]SynVest-1 PET in HD.

👨‍⚕️ Koen Van Laere, MD, PhD, DSc, UZ/KU Leuven📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT06414967

Study to Evaluate Music Therapy on Irritability and Impulsivity in Patients With Huntington's Disease (MUSIC-HD)

🏥 Poitiers University Hospital📍 1 site📅 Started Oct 2024View details ↗
NARecruitingNCT06444217

Gene Therapy Development and Validation for Huntington's Disease Fibro TG-HD

👨‍⚕️ VERNY Christophe, MD, PhD, University Hospital, Angers📍 1 site📅 Started Sep 2024View details ↗
RecruitingNCT06667414

Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers

👨‍⚕️ Clinical Trials, Hoffmann-La Roche📍 45 sites📅 Started Sep 2024View details ↗
RecruitingNCT06475898

Longitudinal Endpoint Assessment of Disease Burden in HD

👨‍⚕️ Jamison Seabury, University of Rochester Center for Health + Technology📍 1 site📅 Started Jun 2024View details ↗
Page 1 of 2Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →